Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retigabine in post-herpetic neuralgia
NCT00612105Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of retigabine in postherpetic neuralgia (PHN), sponsored by Valeant Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
retigabine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00612105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612105.